Project details
- Project period
- 8 Sep 2025 - 7 Sep 2030
- Total cost
- €14 999 800,00
- Global Health EDCTP3 funding
- €14 999 800,00
- Call identifier
- HORIZON_HORIZON-JU-GH-EDCTP3-2024-01-02-two-stage
- Status
- In progress
- Project type
- Research and Innovation Actions (RIA)
- Disease area
- Malaria
- Intervention type
- Vaccines
Consortium map
Coordinator
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- Location
- Oxford, United Kingdom
- EU contribution
- €6 115 012,50
- Total cost
- €6 115 012,50
Scientific project leader
Location: Ouagadougou, Burkina Faso
Beneficiaries
CENTRE FOR MALARIA AND OTHER TROPICAL DISEASES CARE, ILORIN
- Location
- Ilorin, Nigeria
- EU contribution
- €733 434,64
- Total cost
- €733 434,64
EXPRES2ION BIOTECHNOLOGIES APS
- Location
- Horsholm, Denmark
- EU contribution
- €50 000,00
- Total cost
- €50 000,00
THE REGISTERED TRUSTEES OF THE IFAKARA HEALTH INSTITUTE
- Location
- DAR ES SALAAM, Tanzania
- EU contribution
- €625 138,60
- Total cost
- €625 138,60
INSTITUT PASTEUR DE DAKAR
- Location
- Dakar, Senegal
- EU contribution
- €500 000,00
- Total cost
- €500 000,00
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
- Location
- LONDON, United Kingdom
- EU contribution
- €2 104 133,75
- Total cost
- €2 104 133,75
EUROPEAN VACCINE INITIATIVE EV
- Location
- Heidelberg, Germany
- EU contribution
- €50 000,00
- Total cost
- €50 000,00
CENTRE NATIONAL DE RECHERCHE SCIENTIFIQUE ET TECHNOLOGIQUE*INSTITUT DE RECHERCHE EN SCIENCES DE LA SANTE
- Location
- Ouagadougou, Burkina Faso
- EU contribution
- €4 000 000,00
- Total cost
- €4 000 000,00
UNIVERSITY OF SIERRA LEONE
- Location
- FREETOWN, Sierra Leone
- EU contribution
- €822 080,51
- Total cost
- €822 080,51
Related projects

AI detection of parasite infectionsThe MultiplexAI project is developing an easy-to-use add-on for conventional microscopes that deploys artificial intelligence (AI) models to detect...

Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.

The overall goal of this project is to provide scientific evidence for WHO policymaking on the longterm efficacy, safety, acceptability and cost-effectiveness of using R21/Matrix-Malaria...